3-Fluoromethamphetamine
3-Fluoromethamphetamine (3-FMA) is a stimulant drug from the amphetamine class that has been sold online as a designer drug.[1][2][3][4]
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H14FN |
Molar mass | 167.227 g·mol−1 |
3D model (JSmol) | |
| |
|
Legal Status
As of October 2015 3-FMA is a controlled substance in China.[5]
See also
- 2-Fluoroamphetamine (2-FA)
- 2-Fluoromethamphetamine (2-FMA)
- 3-Fluoroamphetamine (3-FA)
- 3-Fluoroethamphetamine (3-FEA)
- 3-Fluoromethcathinone (3-FMC)
- 4-Fluoroamphetamine (4-FA)
- 4-Fluoromethamphetamine (4-FMA)
- 3-Chloromethamphetamine (3-CMA)
References
- Westphal F, Rösner P, Junge T (January 2010). "Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry". Forensic Science International. 194 (1–3): 53–9. doi:10.1016/j.forsciint.2009.10.007. PMID 19900772.
- Nakanishi K, Miki A, Zaitsu K, Kamata H, Shima N, Kamata T, et al. (April 2012). "Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement". Forensic Science International. 217 (1–3): 174–81. doi:10.1016/j.forsciint.2011.11.003. PMID 22154438.
- Kauppila TJ, Flink A, Haapala M, Laakkonen UM, Aalberg L, Ketola RA, Kostiainen R (July 2011). "Desorption atmospheric pressure photoionization-mass spectrometry in routine analysis of confiscated drugs". Forensic Science International. 210 (1–3): 206–12. doi:10.1016/j.forsciint.2011.03.018. PMID 21474259.
- Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (July 2013). "Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry". Forensic Toxicology. 31 (2): 241–250. doi:10.1007/s11419-013-0184-7.
- "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.